• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际协调会议;关于个体病例安全报告传输数据元素的指南;可用性。通知。美国卫生与公众服务部食品药品监督管理局

International Conference on Harmonisation; guidance on data elements for transmission of individual case safety reports; availability. Notice. Food and Drug Administration, HHS.

出版信息

Fed Regist. 1998 Jan 15;63(10):2396-404.

PMID:12296373
Abstract

The Food and Drug Administration (FDA) is publishing a guidance entitled "E2B Data Elements for Transmission of Individual Case Safety Reports." The guidance was prepared under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The guidance is intended to facilitate the standardization of the data elements for the transmission of individual case safety reports for both preapproval and postapproval reporting periods.

摘要

美国食品药品监督管理局(FDA)正在发布一份名为《个体病例安全报告传输的E2B数据元素》的指南。该指南是在人用药品注册技术要求国际协调会议(ICH)的主持下制定的。本指南旨在促进个体病例安全报告在批准前和批准后报告期传输数据元素的标准化。

相似文献

1
International Conference on Harmonisation; guidance on data elements for transmission of individual case safety reports; availability. Notice. Food and Drug Administration, HHS.国际协调会议;关于个体病例安全报告传输数据元素的指南;可用性。通知。美国卫生与公众服务部食品药品监督管理局
Fed Regist. 1998 Jan 15;63(10):2396-404.
2
International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice.国际协调会议;人用药品S7A安全性药理研究指南;可获取性。通知。
Fed Regist. 2001 Jul 13;66(135):36791-2.
3
International Conference on Harmonisation; guidance on Addendum to E2C Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs; availability. Notice.国际协调会议;《E2C临床安全数据管理附录:已上市药品定期安全更新报告》指南;可获取性。通知。
Fed Regist. 2004 Feb 5;69(24):5551-2.
4
International Conference on Harmonisation; guidance on the duration of chronic toxicity testing in animals (rodent and nonrodent toxicity testing); availability. Notice. Food and Drug Administration, HHS.国际协调会议;动物慢性毒性试验持续时间指南(啮齿类和非啮齿类毒性试验);可获取性。通知。美国卫生与公众服务部食品药品管理局
Fed Regist. 1999 Jun 25;64(122):34259-60.
5
International Conference on Harmonisation; guidance on specifications: test procedures and acceptance criteria for biotechnological/biological products. Notice. Food and Drug Administration, HHS.国际协调会议;生物技术/生物制品的规格、测试程序及验收标准指南。通知。美国卫生与公众服务部食品药品监督管理局
Fed Regist. 1999 Aug 18;64(159):44928-35.
6
International Conference on Harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population; availability. Notice.国际协调会议;关于儿科人群药品E11临床研究的指南;可获取性。通知。
Fed Regist. 2000 Dec 15;65(242):78493-4.
7
International Conference on Harmonisation; evaluation of stability data; availability. Notice.国际协调会议;稳定性数据评估;可获得性。通知。
Fed Regist. 2004 Jun 8;69(110):32010-1.
8
International Conference on Harmonisation: guidance on testing for carcinogenicity of pharmaceuticals. Notice. Food and Drug Administration, HHS.国际协调会议:药品致癌性测试指南。通知。美国卫生与公众服务部食品药品监督管理局
Fed Regist. 1998 Feb 23;63(35):8983-6.
9
International Conference on Harmonisation; guidance on Q1A stability testing of new drug substances and products; availability. Notice.国际协调会议;新原料药和制剂的Q1A稳定性试验指南;可获取性。通知。
Fed Regist. 2001 Nov 7;66(216):56332-3.
10
International Conference on Harmonisation; Guidance on S9 Nonclincal Evaluation for Anticancer Pharmaceuticals; availability. Notice.国际协调会议;S9 抗癌药物非临床评价指南;可获取性。通知。
Fed Regist. 2010 Mar 8;75(44):10487-8.

引用本文的文献

1
High versus standard blood pressure target in hypertensive high-risk patients undergoing elective major abdominal surgery: a study protocol for the HISTAP randomized clinical trial.接受择期腹部大手术的高血压高危患者的高血压目标与标准血压目标对比:HISTAP随机临床试验的研究方案
J Anesth Analg Crit Care. 2023 Dec 1;3(1):50. doi: 10.1186/s44158-023-00133-3.
2
Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases.数据库概况变化对药物安全性评估的影响:日本病例自发不良事件报告分析
Drug Des Devel Ther. 2015 Jun 12;9:3031-41. doi: 10.2147/DDDT.S81998. eCollection 2015.
3
Guidelines for submitting adverse event reports for publication.
提交不良事件报告以供发表的指南。
Drug Saf. 2007;30(5):367-73. doi: 10.2165/00002018-200730050-00001.
4
The Internet and drug safety: what are the implications for pharmacovigilance?互联网与药物安全:对药物警戒有何影响?
Drug Saf. 1999 Feb;20(2):95-107. doi: 10.2165/00002018-199920020-00001.